217330 — Cytogen Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩109bn
- KR₩94bn
- KR₩26bn
Annual cashflow statement for Cytogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10,871 | -18,771 | -15,770 | -17,116 | -12,340 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,255 | 10,950 | 6,553 | 7,791 | 5,795 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 272 | 129 | -289 | -2,293 | -3,583 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5,230 | -6,379 | -7,594 | -9,529 | -6,954 |
| Capital Expenditures | -1,997 | -745 | -2,622 | -1,124 | -2,038 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3,588 | -5,909 | 2,886 | -23,225 | -9,826 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5,585 | -6,654 | 263 | -24,349 | -11,864 |
| Financing Cash Flow Items | 43.3 | 14.2 | -2.26 | 28.1 | 1.62 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 30,027 | -1,039 | 46,236 | 9,172 | -1,360 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19,212 | -14,410 | 38,960 | -24,724 | -20,210 |